GVRP StepsBio Launches GSRC in India's Lifesciences Hub
GVRP and Steps Biosciences have collaborated to launch the GVRP StepsBio Research Centre (GSRC) at 1BLR's Lifescapes cluster, aiming to advance formulations research and streamline drug development processes.
Highlights
- •GVRP and Steps Biosciences partner to set up GSRC in Bengaluru's Lifecaspses
- •New facility focuses on complex drug delivery systems, sterile injectables, and differentiated dosage forms
- •Integrated platform from preclinical research to complex formulation development
- •Investment in AI-driven technologies for enhanced decision-making and predictive stability modeling
Hyderabad-based research organization GV Research Platform (GVRP) has partnered with Steps Biosciences to establish the GVRP StepsBio Research Centre (GSRC). Located within 1BLR's Lifescapes cluster in Bengaluru, this 15,000 sq. ft. facility will serve as a hub for advanced formulations research and development.
GSRC: A Center of Excellence for Advanced Formulations
Focusing on complex drug delivery systems, sterile injectables, and differentiated dosage forms, the GSRC integrates state-of-the-art scientific infrastructure with robust workflows. The facility aims to streamline the entire R&D process from preclinical research to final product design.
"We have created a facility that caters to global R&D requirements in drug development," commented Kalyan Korisapati, co-founder of GVRP. "Our goal is to offer an integrated platform where partners can undertake complex formulation development and reduce their product development timelines significantly."
In parallel with their scientific advancements, Steps Biosciences is investing in infrastructure for AI-driven formulation design and predictive stability modeling. This strategic partnership between GVRP and Steps Biosciences promises to enhance decision-making processes and significantly hasten the delivery of innovative therapies.
Manoj Nerurkar, founder of Steps Biosciences, added: "Integrating advanced technologies with scientific excellence will allow us to bring better healthcare solutions to patients much faster. Our platform is designed to handle complex challenges in drug development."
